Pernicious Anaemia & Hydroxocobolamine

Scope and Content

There are two items of correspondence dated January 1962 between Wilkinson and R. Brown of the Ipswich & East Suffolk Hospital regarding a specific named case of pernicious anaemia that was treated with Hydroxocobolamine with details of his resultant blood count and sending a second specimen to Wilkinson for serum B12 estimation.

There are also two items of correspondence from J.J.F. Merry of Merck Sharp & Dohme Ltd. dated June and August 1961 regarding their new product Hydroxocobalamin, which they hope will give longer therapeutic blood levels than existing preparations and sending Wilkinson supplies of it for a comparative study with cyanocobalamin.

A printed table showing the effect on haemoglobin levels of 5 patients after 3 weeks of treatment with Hydroxocobalamin.

Small information leaflet produced by Glaxo Laboratories Ltd. for Crystamycin, for use in acute attacks of chronic bronchitis, and Neo-Cytamen, an injection of Hydroxocobalamin for use in pernicious anaemia.

Access Information

This file contains personal medical information of several individuals that is less than 100 years old and closed under the terms of the Data Protection Act 1998. Please consult the archivist before issuing.